Pharmacological evidence supporting a role for central corticotropin-releasing factor2 receptors in behavioral, but not endocrine, response to environmental stress

Journal of Pharmacology and Experimental Therapeutics

Volumn 302, Issue 1, 2002, Pages 145-152

  Pelleymounter, Mary Ann ^a   Joppa, Margaret ^a   Ling, Nicholas ^b   Foster, Alan C ^a,c  

^a Aesthetics Inc   (United States)

^b Bristol Meyers Squibb ^*  (United States)

^c NEUROCRINE BIOSCIENCES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI SAUVAGINE 30; ASTRESSIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; DIAZEPAM; FLUOXETINE; UNCLASSIFIED DRUG; UROCORTIN II;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MAZE TEST; MOUSE; NEUROENDOCRINOLOGY; NEUROMODULATION; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; STRESS;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CORTICOTROPIN-RELEASING HORMONE; ENDOCRINE GLANDS; ENVIRONMENT; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MICE, INBRED BALB C; PEPTIDE FRAGMENTS; PITUITARY-ADRENAL SYSTEM; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RESTRAINT, PHYSICAL; STRESS, PSYCHOLOGICAL;

EID: 0036088693     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.302.1.145     Document Type: Article

References (45)

1. Chronic administration of the selective corticotropin releasing factor 1 receptor antagonist CP-154,526: Behavioral, endocrine and neurochemical effects in the rat
2. Mice deficient for corticotropin releasing hormone receptor-2 display anxiety-like behavior and are hypersensitive to stress
3. Antalarmin blockade of corticotropin releasing hormone-induced hypertension in rats
4. Intraventricular corticotropin releasing factor enhances behavioral effects of novelty
5. Corticotropin releasing factor (CRF) receptor antagonist blocks activating and "anxiogenic" actions of CRF in the rat
6. 1 receptor mRNA expression
7. Quantitative trait loci affecting the behavior of A/J and CBA/J intercross mice in the elevated plus maze
8. Dissociation of locomotor activation and suppression of food intake induced by CRF in CRFR1-deficient mice
9. Mouse strain differences in the behavioral effects of corticotropin-releasing factor (CRF) and the CRF antagonist alpha helical CRF (9-41)
10. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2
11. The impact of the nonpeptide corticotropin releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress
12. Cloning and characterization of human urocortin
13. Physiological and behavioral responses to corticotropin-releasing factor administration: Is CRF a mediator of anxiety and the stress response
14. Factors controlling measures of anxiety and responses to novelty in the mouse
15. Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone
16. Characterization of corticotropin releasing factor receptor subtypes
17. Potent, structurally constrained agonists and competitive antagonists of corticotropin releasing factor
18. The role of corticotropin-releasing hormone in the dorsal raphe nucleus in mediating the behavioral consequences of uncontrollable stress
19. 125I-Antisauvagine-30: A novel and specific high-affinity radioligand for the characterization of corticotropin releasing factor type 2 receptors
20. Attenuation of fear conditioning by antisense inhibition of brain corticotropin releasing factor-2 receptor
21. Antagonism of endogenous CRH systems attenuates stress-induced freezing behavior in rats
22. Effects of corticotropin releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus
23. Deletion of CRH-2 reveals an anxiolytic role for corticotropin releasing hormone receptor-2
24. Corticotropin-releasing factor increases in vitro firing rates of serotonergic neurons in the rat dorsal raphe nucleus: Evidence for activation of a topographically organized mesolimbocortical serotonergic system
25. Corticotropin releasing hormone type 2 receptors in the dorsal raphe nucleus are necessary for the development of learned helplessness
26. Characterization of a novel and potent corticotropin releasing factor antagonist in rats
27. Septal neurons respond to activation of baro- and chemoreceptors in the rat
28. CRH signalling in the bed nucleus of the stria terminalis is involved in stress-induced cardiac vagal activation in conscious rats
29. The role of CRH type 1 receptor in autonomic responses to corticotropin releasing hormone in the rat
30. Evaluation of marble-burying behavior as a model of anxiety
31. Effects of 5-HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agents
32. Receptor binding, behavioral and electrophysiological profiles of nonpeptide corticotropin releasing factor subtype I receptor antagonists CRA1000 and CRA1001
33. Validation of open/closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
34. Regulation of serotonin release in the lateral septum and striatum by corticotropin releasing factor
35. Modulation of learning and anxiety by corticotropin releasing factor (CRF) and stress: Differential roles of CRF receptors 1 and 2
36. Urocortin II: A member of the corticotropin releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors
37. 125I]sauvagine binding to CRH2 receptors: Membrane homogenate and autoradiographic studies
38. Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): Development of CRFR2B-selective antisauvagine-30
39. Accelerated norepinephrine turnover in peripheral tissues after ventromedial hypothalamic stimulation in rats
40. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response and aberrant neuroendocrine development
41. Antagonism of CRF2 receptors produces anxiolytic behavior in animal models of anxiety
42. Mental health: A report of the surgeon general
43. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse
44. Changes in arterial blood pressure alter activity of electrophysiologically identified single units of the bed nucleus of the stria terminalis